A method of treating cancer comprising a vegf-b antagonist

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/18 (2006.01) A61K 39/395 (2006.01) A61P 35/00 (2006.01) C07K 16/22 (2006.01)

Patent

CA 2575901

The present invention relates generally to the field of cancer therapy and prophylaxis. More particularly, the present invention provides growth factor antagonists which inhibit the growth of cancers including tumors and pre- cancerous tissue. Even more particularly, the present invention is directed to antagonists of vascular endothelial growth factor-B and their use to inhibit the growth of cancer including tumor tissue and pre-cancerous tissue.

La présente invention concerne de façon générale le domaine de la thérapie et de la prophylaxie du cancer. Plus précisément, la présente invention concerne des antagonistes de facteur de croissance qui inhibent la croissance de cancers, notamment de tumeurs et de tissu précancéreux. Encore plus précisément, la présente invention concerne des antagonistes du facteur de croissance endothélial vasculaire B et leur utilisation pour inhiber la croissance du cancer, notamment de tissu tumoral et de tissu précancéreux.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

A method of treating cancer comprising a vegf-b antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A method of treating cancer comprising a vegf-b antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A method of treating cancer comprising a vegf-b antagonist will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1456576

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.